Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Andriani
Observed names:
Andriani, Francesca,
F Andriani,
F. Andriani,
FRANCESCA ANDRIANI
Institutions:
Centro Cardiologico Monzino,
Institut de Génomique Fonctionnelle de Lyon
Observed institutions:
Lyon 1 Université,
École Normale Supérieure de Lyon,
Centre National de la Recherche Scientifique,
Baylor College of Medicine,
University Hospital of Bern,
Centro Cardiologico Monzino,
Institut de Génomique Fonctionnelle de Lyon,
Fondazione IRCCS Istituto Nazionale dei Tumori
show all 8
ORCID:
0000-0002-6178-7789
Observed ORCID:
0000-0002-6178-7789
OpenAlex ID:
A5026088340
Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatment
2009
·
Giulia Bertolini
, Luca Roz
, et al.
·
Proceedings of the National Academy of Sciences
·
783
Effects of Prolonged Storage of Whole Plasma or Isolated Plasma DNA on the Results of Circulating DNA Quantification Assays
2005
·
Gabriella Sozzi
, Luca Roz
, et al.
·
JNCI Journal of the National Cancer Institute
·
168
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
2002
·
Alessandra Bearzatto
, Davide Conte
, et al.
·
PubMed
·
144
Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types
2015
·
Paolo Gandellini
, Francesca Andriani
, et al.
·
Seminars in Cancer Biology
·
141
Conversion to stem‐cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells
2015
·
Francesca Andriani
, Giulia Bertolini
, et al.
·
Molecular Oncology
·
120
PDF
Plasma DNA Quantification in Lung Cancer Computed Tomography Screening
2008
·
Gabriella Sozzi
, Luca Roz
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
106
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM− Lung Cancer–Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
2015
·
Giulia Bertolini
, Lucia D'Amico
, et al.
·
Cancer Research
·
102
Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.
2001
·
X Li
, M Marani
, et al.
·
PubMed
·
100
Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk
2018
·
Orazio Fortunato
, Cristina Borzi
, et al.
·
International Journal of Cancer
·
80
PDF
Detecting lung cancer in plasma with the use of multiple genetic markers
2003
·
Francesca Andriani
, Davide Conte
, et al.
·
International Journal of Cancer
·
80
PDF
Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project
2008
·
Carla Verri
, Luca Roz
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
63
Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
2018
·
Francesca Andriani
, Elena Landoni
, et al.
·
BMC Cancer
·
61
PDF
Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non–Small Cell Lung Cancer
2016
·
Elena Tassi
, Giulia Grazia
, et al.
·
Cancer Research
·
58
Increased Sensitivity to Cisplatin in Non-Small Cell Lung Cancer Cell Lines after FHIT Gene Transfer
2006
·
F. Andriani
, P. Perego
, et al.
·
Neoplasia
·
45
PDF
Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin‐mediated interactions
2020
·
Cecilia Gardelli
, Laura Russo
, et al.
·
Cancer Science
·
40
PDF
MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner
2018
·
Francesca Andriani
, Maria Teresa Majorini
, et al.
·
Journal of Hematology & Oncology
·
39
PDF
Dose-dependent effect of FHIT-inducible expression in Calu-1 lung cancer cell line
2004
·
Andrea Cavazzoni
, Pier Giorgio Petronini
, et al.
·
Oncogene
·
38
The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression
2004
·
Luca Roz
, Francesca Andriani
, et al.
·
Oncogene
·
37
Use of the Probasin Promoter ARR2PB to Express Bax in Androgen Receptor-Positive Prostate Cancer Cells
2001
·
F. Andriani
, B. Nan
, et al.
·
JNCI Journal of the National Cancer Institute
·
36
Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells
2024
·
Monica Parodi
, Giovanni Centonze
, et al.
·
Journal for ImmunoTherapy of Cancer
·
27
PDF
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
2022
·
Massimo Moro
, Orazio Fortunato
, et al.
·
Pharmaceuticals
·
26
PDF
CNN-Based Cell Analysis: From Image to Quantitative Representation
2022
·
Cédric Allier
, Lionel Hervé
, et al.
·
Frontiers in Physics
·
25
Inactivation of Both FHIT and p53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer
2012
·
Francesca Andriani
, Elena Roz
, et al.
·
Journal of Thoracic Oncology
·
25
Monogene and Polygene Therapy for the Treatment of Experimental Prostate Cancers by Use of Apoptotic Genes bax and bad Driven by the Prostate-Specific Promoter ARR 2 PB
2002
·
Ye Zhang
, Jiang Yu
, et al.
·
Human Gene Therapy
·
25
Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung
2016
·
Roberto Lugo
, Marta Gabasa
, et al.
·
Oncotarget
·
24
PDF
Show more works
View as search
Works count:
75
Citation count:
2,502
H-index:
24
I10-index:
29
Year
Topic
Type